Indication: VONVENDI [von Willebrand factor (recombinant)] is used in adults (age 18 years and older) diagnosed with von Willebrand disease to: treat and control bleeding episodes and prevent excessive bleeding during and after surgery

Menu
VONVENDI is now approved for perioperative management of bleeding in adults with VWD VONVENDI is now approved for perioperative management of bleeding in adults with VWD
For adults with von Willebrand disease (VWD)

VONVENDI®

[von Willebrand factor (Recombinant)]

Is in your corner

Recombinant Treatment and Bleed Control

See details about treatment

Vonvendi Free Trial Program

Eligible patients can try VONVENDI with 3 free doses

Learn more

The first & only recombinant von Willebrand factor

Learn about a treatment engineered for the treatment of VWD

See details

Treatment Outcomes

See how VONVENDI controlled bleeding
episodes in clinical studies

Explore the data
Learn about VWD info at a glance

Copay savings from Shire

Shire's CoPay Program offers financial assistance to eligible patients.

Get more information

How to use

Get information on mixing, storing, and dosing VONVENDI

Take me to the instructions

VWD info at a glance

Whether you’ve just started learning or need to jog your memory, you can brush up on the basics

Teach me more

Stay Updated

Register for email from Shire and VONVENDI

Sign me up!